OGN.NYSEOrganon & CO

Form 4: Organon & Co. Director Rochelle Lazarus Reports Phantom Stock

Sentiment:

Statement of Changes in Beneficial Ownership


Rochelle B. Lazarus, a Director at Organon & Co., reported transactions involving phantom stock units, reflecting her beneficial ownership and participation in the company's savings plan.

Summary

  • Rochelle B. Lazarus, a Director at Organon & Co., has filed a Form 4 detailing transactions related to phantom stock units.
  • These phantom stock units are economically equivalent to shares of Organon common stock on a 1-for-1 basis.
  • The units were acquired under the Organon Non-Employee Director Savings Plan and are payable in cash upon termination of service as a director.
  • The reported transactions include acquisitions of phantom stock units, with dividend reinvestments noted on specific dates in 2025 and 2026.
  • Following these transactions, Lazarus beneficially owns 81,141.135 phantom stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions related to director compensation rather than significant strategic or financial events.

Positives

  • Director Rochelle B. Lazarus continues to hold a significant beneficial ownership in Organon & Co. through phantom stock units, indicating ongoing commitment.
  • The acquisition of phantom stock units through dividend reinvestment suggests a mechanism for increasing director holdings over time.
  • The structure of the Non-Employee Director Savings Plan allows for cash settlement upon termination, providing a clear exit strategy for these units.

Negatives

  • The filing solely reports on phantom stock units, which are not direct equity holdings and are payable in cash, meaning Lazarus does not directly own common stock through these instruments.
  • The value of these phantom stock units is tied to the company's common stock price, exposing Lazarus to market fluctuations without direct equity ownership.

Risks

  • The value of the phantom stock units is subject to the market performance of Organon & Co. common stock.
  • The cash settlement of phantom stock units upon termination of service as a director means the ultimate payout is dependent on the company's financial health at that future date.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a report of past transactions related to beneficial ownership.

Management Comments

  • "Each phantom stock unit is an economic equivalent of one share of Organon & Co. ('Organon') common stock, or 1-for-1."
  • "Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the 'Plan') and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan."
  • "Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026."

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of phantom stock units by Organon & Co. for its directors is a common practice in corporate governance, allowing for compensation tied to stock performance without direct equity dilution.

Related Party Transactions

  • The transactions involve phantom stock units granted under the Organon Non-Employee Director Savings Plan, which is a form of compensation to a related party (Director Rochelle B. Lazarus).

Stakeholder Impact

  • Shareholders: The filing provides transparency on director compensation and beneficial ownership, which is important for corporate governance and investor confidence.
  • Directors: Rochelle B. Lazarus's holdings reflect her continued engagement and economic interest in the company's performance.
  • Employees: While not directly impacting employees, the compensation structure for directors is part of the overall corporate governance framework.

Next Steps

  • Phantom stock units are payable in cash upon settlement after the reporting person's termination of service as a director.

Key Dates

DateDescription
06/12/2026Earliest transaction date reported and date of phantom stock unit acquisition.
09/11/2025Date of dividend reinvestment for phantom stock units.
12/11/2025Date of dividend reinvestment for phantom stock units.
03/12/2026Date of dividend reinvestment for phantom stock units.
06/11/2026Date of dividend reinvestment for phantom stock units.
06/15/2026Date of filing signature.

Keywords

Organon & Co., OGN, Form 4, Rochelle B. Lazarus, Phantom Stock, Director, Beneficial Ownership, Securities Exchange Act, Non-Employee Director Savings Plan, Dividend Reinvestment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.